Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Sponsor: Senthil Sadhasivam • ClinicalTrials.gov ID: NCT05380531
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothers and their infants
Interventions
-
Preoperative Genotyping
(Diagnostic test)
Genotype based risk prediction and personalized pain management
Eligibility criteria
Conditions
Locations
- Riley Children's Hospital- Clinics / Labor and Delivery Unit — Indianapolis, Indiana, United States
- Washington University Hospital — St Louis, Missouri, United States
- UPMC Magee Women's Hospital — Pittsburgh, Pennsylvania, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record